Find the right fit for you - faster
Get tailored insights about working at NeuExcell Therapeutics in one quick step.
NeuExcell Therapeutics Snapshot
Our mission is to serve patients by translating our pioneering neuroregenerative platform technology into clinical practice.
Our vision is to restore health and improve the lives of patients suffering from neurodegeneraive diseases and CNS injuries.
Our vision is to restore health and improve the lives of patients suffering from neurodegeneraive diseases and CNS injuries.
NeuExcell Therapeutics was founded in 2016 by Dr. Gong Chen and Ms. Jie Xu. Today, NeuExcell has grown to become a gene therapy company focusing on improving the lives of patients suffering from neurodegenerative diseases. The company has discovered a disruptive technology that focuses on regenerating neurons in the brain. This powerful platform has the potential to transform patient outcomes and change lives. We are now rapidly expanding our R&D efforts, toward our goal of developing effective and safe treatments for serious neurodegenerative diseases including stroke, Huntington’s Disease, ALS, and Traumatic Brain Injury.
NeuExcell has established their long-term corporate headquarters in the heart of Philadelphia’s Cellicon Valley region to enable the company to build a world-class team tapping into the veteran cell and gene therapy talent in Greater Philadelphia.
We look for enthusiastic people who want to be a part of contributing to innovative and effective treatments for patients suffering from devastating neurodegenerative diseases.
Together, we aim to improve the quality of life of millions of patients worldwide by using the power of gene therapy to restore damaged neuronal tissue.
NeuExcell has established their long-term corporate headquarters in the heart of Philadelphia’s Cellicon Valley region to enable the company to build a world-class team tapping into the veteran cell and gene therapy talent in Greater Philadelphia.
We look for enthusiastic people who want to be a part of contributing to innovative and effective treatments for patients suffering from devastating neurodegenerative diseases.
Together, we aim to improve the quality of life of millions of patients worldwide by using the power of gene therapy to restore damaged neuronal tissue.
